Today: 11 November 2025
Subscribe
Browse Tag

manufacturing

JELD‑WEN to cut 850 jobs and trims 2025 outlook after deep Q3 loss; Europe business under strategic review

JELD‑WEN to cut 850 jobs and trims 2025 outlook after deep Q3 loss; Europe business under strategic review

Date: Nov. 6, 2025 Key takeaways What’s new today (Nov. 6) Following Monday’s earnings release, JELD‑WEN confirmed it will shed ~850 positions across North America and corporate functions and is reviewing strategic alternatives for its Europe segment. The workforce actions, slated to be completed by the end of 2025, are part of a broader cost‑reset amid weaker demand and price‑cost pressure. Q4 Capital Charlotte’s local press reports the reductions will include positions in the Charlotte area, adding a regional dimension to the restructuring at the company’s headquarters. Charlotte Observer The numbers: Q3 at a glance The Associated Press likewise summarized
6 November 2025
 ·  ·  ·  ·  · 
Global Market Turmoil: Asia’s Factories Stumble, US Tariffs Bite, Oil Soars – What’s Next?

Global Market Turmoil: Asia’s Factories Stumble, US Tariffs Bite, Oil Soars – What’s Next?

In-Depth Analysis: Asia’s Manufacturing Slowdown: Business surveys on Nov 3–4 revealed broad weakness. China’s S&P Global (private) PMI dipped to 50.6 in October reuters.com as new export orders fell sharply amid tariff concerns. Official data also showed China’s factory output contracting for the 7th straight month. Japan’s manufacturing PMI was even weaker – 48.2 in October (from 48.5), its lowest since Mar 2024 reuters.com. Pollyanna De Lima of S&P noted, “demand weakness, particularly in the automotive and semiconductor sectors, weighed on Japanese manufacturing” reuters.com, though firms are optimistic that U.S. tariffs’ “detrimental impact… will fade” and future output will recover
5 November 2025
 ·  ·  ·  · 
Xometry (XMTR) Stock Soars on Record Q3 Earnings – What’s Next for This AI Manufacturing Marketplace?

Xometry (XMTR) Stock Soars on Record Q3 Earnings – What’s Next for This AI Manufacturing Marketplace?

Key Facts (as of Nov 4, 2025) Stock Price & Recent Performance Xometry’s stock (NASDAQ: XMTR) has been on a tear in early November 2025. On Nov 4, 2025, shares skyrocketed ~24% intraday following the Q3 earnings announcement, peaking around $60 and nearing a 52-week high of $60.68 ainvest.com. It closed the day at roughly $60.23 (up from $48.57 the prior session) investing.com. This record high represents a dramatic one-day gain and continues a strong upward trend – the stock has more than tripled from its 52-week low of ~$18.59 earlier in the year investing.com. In the days leading up
4 November 2025
 ·  ·  ·  ·  · 
Why Puerto Rico Could Reclaim Its Status as a Pharmaceutical Powerhouse: The Hidden Opportunity Behind Reshoring

Why Puerto Rico Could Reclaim Its Status as a Pharmaceutical Powerhouse: The Hidden Opportunity Behind Reshoring

Puerto Rico’s pharmaceutical roots and the Section 936 story For much of the late 20th century, Puerto Rico was an unlikely but critical component of America’s medicine chest. The island’s status as a U.S. territory provided access to federal intellectual‑property protections, Food and Drug Administration (FDA) oversight and the “Made in USA” label—all while offering costs and tax advantages more akin to an emerging market. The most potent driver was Section 936, enacted in 1976, which exempted profits earned by U.S. corporations in Puerto Rico from federal income taxes. Pharmaceutical giants set up dozens of plants, creating tens of thousands of jobs and
6 October 2025
 ·  ·  ·  · 
China’s Manufacturing Slump Deepens: Factories Freeze for 6th Month – Experts Warn of Lingering Weakness

China’s Manufacturing Slump Deepens: Factories Freeze for 6th Month – Experts Warn of Lingering Weakness

Manufacturing Activity Stalls – PMI Still in Contraction China’s official manufacturing PMI in September was 49.8, up slightly from 49.4 in August but still indicating contraction bloomberg.com reuters.com. This means more factories are shrinking output than expanding. September marked the sixth consecutive month the PMI stayed below 50, the longest downturn since mid-2019 bloomberg.com. Reuters notes this “prolonged slump” reflects the economy’s struggle with weak demand and trade pressures reuters.com reuters.com. As one analyst put it, “The rebound reflects a seasonal uptick… but a continued upcycle is still some way off” given capacity and global headwinds reuters.com. Bloomberg also highlighted
30 September 2025
 ·  ·  ·  ·  · 
Why 5G Internet Providers Are Replacing Cable Faster Than You Think

Chemical Giant Celanese Goes All-In on Private 5G – A Game-Changer for Its Factories

Industry 4.0 Demands New Connectivity Modern “smart” factories rely on endless sensors, robots and automated machinery. Experts note that today’s factories run on data and communication – not just assembly lines thefastmode.com thefastmode.com. But traditional Wi‑Fi or public cellular often falters indoors or around heavy equipment. As one analyst explains, Wi‑Fi can’t handle mobility and coverage in a giant metal plant; it suffers interference and dropped links rcrwireless.com thefastmode.com. In contrast, a private 5G network is a closed cellular system dedicated to one site. It delivers low-latency, high-capacity, reliable connectivity that can span large areas and penetrate tough environments thefastmode.com
29 September 2025
 ·  ·  ·  ·  · 
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Richmond’s New Pharma Giant: Overview of Lilly’s $5B Factory Eli Lilly’s forthcoming Richmond-area factory is set to be one of the largest and most advanced pharmaceutical manufacturing sites in the world. At a cost of $5 billion, Lilly will construct a high-tech production campus in Goochland County’s West Creek Business Park, a site that had been prepped for a previous project and now deemed “the perfect spot” for fast construction washingtonpost.com. The facility’s core mission: make more of the critical drug ingredients that Lilly usually sources overseas, right here on U.S. soil washingtonpost.com washingtonpost.com. Scale and Scope: The plant will
16 September 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Go toTop